Maturitas
Volume 55 , Pages S37-S46 , 1 November 2006

The flavonoid apigenin inhibits the proliferation of prostatic stromal cells via the MAPK-pathway and cell-cycle arrest in G1/S

  • Jasmin Bektic

      Affiliations

    • Department of Urology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria
    • Both authors contributed equivalently to this study.
  • ,
  • Roman Guggenberger

      Affiliations

    • Department of Urology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria
    • Both authors contributed equivalently to this study.
  • ,
  • Barbara Spengler

      Affiliations

    • Bionorica AG, Neumarkt, Germany
  • ,
  • Volker Christoffel

      Affiliations

    • Bionorica AG, Neumarkt, Germany
  • ,
  • Alexandre Pelzer

      Affiliations

    • Department of Urology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria
  • ,
  • Andreas P. Berger

      Affiliations

    • Department of Urology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria
  • ,
  • Reinhold Ramoner

      Affiliations

    • Department of Urology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria
  • ,
  • Georg Bartsch

      Affiliations

    • Department of Urology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria
  • ,
  • Helmut Klocker

      Affiliations

    • Department of Urology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 50 504 24818; fax: +43 50 504 67 24818.

References 

  1. Thorpe A, Neal D. Benign prostatic hyperplasia. Lancet. 2003;361(9366):1359–1367
  2. Cunha GR, Chung LW, Shannon JM, Taguchi O, Fujii H. Hormone-induced morphogenesis and growth: role of mesenchymal–epithelial interactions. Recent Prog Horm Res. 1983;39:559–598
  3. Gu F. Changes in the prevalence of benign prostatic hyperplasia in China. Chin Med J (Engl). 1997;110(3):163–166
  4. Adlercreutz H, Honjo H, Higashi A, et al. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr. 1991;54(6):1093–1100
  5. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet. 1993;342(8881):1209–1210
  6. Santti R, Makela S, Strauss L, Korkman J, Kostian ML. Phytoestrogens: potential endocrine disruptors in males. Toxicol Ind Health. 1998;14(1-2):223–237
  7. Evans BA, Griffiths K, Morton MS. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol. 1995;147(2):295–302
  8. Fotsis T, Pepper MS, Montesano R, et al. Phytoestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metab. 1998;12(4):649–666
  9. Kim H, Peterson TG, Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr. 1998;68(6 Suppl):1418S–1425S
  10. Messina MJ, Loprinzi CL. Soy for breast cancer survivors: a critical review of the literature. J Nutr. 2001;131(11 Suppl):3095S–3108S
  11. Hong SJ, Kim SI, Kwon SM, Lee JR, Chung BC. Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Med J. 2002;43(2):236–241
  12. Duthie G, Crozier A. Plant-derived phenolic antioxidants. Curr Opin Lipidol. 2000;11(1):43–47
  13. Kim YJ, Ahn JJ, Woo BH. The effect of cytokine mediators on prostaglandin inhibition by human decidual cells. Am J Obstet Gynecol. 1998;179(1):146–149
  14. Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, Birt DF. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog. 2000;28(2):102–110
  15. Caltagirone S, Rossi C, Poggi A, et al. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer. 2000;87(4):595–600
  16. Wei H, Tye L, Bresnick E, Birt DF. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res. 1990;50(3):499–502
  17. Gupta S, Afaq F, Mukhtar H. Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun. 2001;287(4):914–920
  18. Horninger W, Berger A, Pelzer A, et al. Screening for prostate cancer: updated experience from the Tyrol study. Curr Urol Rep. 2004;5:220–225
  19. Boesch ST, Corvin S, Zhang J, Rogatsch H, Bartsch G, Klocker H. Modulation of the differentiation status of cultured prostatic smooth muscle cells by an alpha1-adrenergic receptor antagonist. Prostate. 1999;39(4):226–233
  20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254
  21. Isaacs JT. Role of androgens in prostatic cancer. Vitam Horm. 1994;49:433–502
  22. Cooke PS, Young P, Hess RA, Cunha GR. Estrogen receptor expression in developing epididymis, efferent ductules, and other male reproductive organs. Endocrinology. 1991;128(6):2874–2879
  23. Gupta S, Afaq F, Mukhtar H. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene. 2002;21(23):3727–3738
  24. Bektic J, Berger AP, Pfeil K, Dobler G, Bartsch G, Klocker H. Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta. Eur Urol. 2004;45(2):245–251[discussion 251]
  25. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139(10):4252–4263
  26. Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol. 2000;60(8):1051–1059

PII: S0378-5122(06)00237-4

doi: 10.1016/j.maturitas.2006.06.015

Maturitas
Volume 55 , Pages S37-S46 , 1 November 2006